Netanya, Israel

Menasse Nussim

This inventor holds 1 USPTO granted patent. Top assignee: Plantex Ltd.. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Menasse Nussim. Retrieved from https://idiyas.com/inventor/menasse-nussim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Menasse Nussim: Innovator in Antibiotic Development

Introduction

Menasse Nussim is a notable inventor based in Netanya, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. His innovative work has led to the creation of a patent that addresses important aspects of antibiotic preparation.

Latest Patents

Menasse Nussim holds a patent for a process for preparing β-lactam antibiotics. This patent includes compounds of a specific formula, which are crucial in the development of effective antibiotic treatments. The patent highlights the innovative methods that Nussim has developed to enhance the efficacy of these compounds.

Career Highlights

Nussim is associated with Plantex Ltd., where he applies his expertise in pharmaceutical research and development. His work at the company has been instrumental in advancing antibiotic formulations and improving healthcare outcomes.

Collaborations

Throughout his career, Menasse Nussim has collaborated with esteemed colleagues such as Joseph Kaspi and Moshe Gross. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of antibiotic research.

Conclusion

Menasse Nussim's contributions to antibiotic development through his patent and work at Plantex Ltd. underscore his role as a significant figure in pharmaceutical innovation. His dedication to improving antibiotic formulations continues to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…